# KTTA catalysts: Pasithea Therapeutics Corp. PDUFA dates and FDA events

Canonical: https://sec-api.dev/companies/ktta/catalysts

> Pasithea Therapeutics Corp. (KTTA) has no upcoming catalysts in this calendar. The latest recorded is the PAS-004 trial start, Dec 2023.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: month only.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Company

| Field | Value |
| --- | --- |
| Name | Pasithea Therapeutics Corp. |
| Ticker | KTTA (Nasdaq) |
| SEC CIK | 1841330 |
| SIC | 2834 |
| SEC filings | https://sec-api.dev/companies/ktta |

## Cash runway

Cash $41.2M as of 2026-09-30; quarterly burn $4.5M; about 27.6 months of runway at that rate (XBRL company facts, accession 0001213900-26-119886).

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| Dec 2023 | [PAS-004 trial start](https://sec-api.dev/pdufa/pas-004) | KTTA | MAPK pathway-driven advanced tumors | completed | "In December 2023, the Company initiated its ongoing Phase 1 open-label, dose escalation trial of PAS-004 in patients with MAPK pathway-driven advanced tumors at sites in the United States and in Eastern Europe." ([SEC Form 10-Q](https://www.sec.gov/Archives/edgar/data/1841330/000121390026119886/ea0310948-10q_pasithea.htm)) |

## Drugs

- [PAS-004](https://sec-api.dev/pdufa/pas-004): mapk pathway-driven advanced tumors

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/companies/ktta/catalysts.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "KTTA catalysts: Pasithea Therapeutics Corp. PDUFA dates and FDA events." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/companies/ktta/catalysts

```bibtex
@misc{secapidev_companies_ktta_catalysts_20261116,
  title        = {KTTA catalysts: Pasithea Therapeutics Corp. PDUFA dates and FDA events},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/companies/ktta/catalysts}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_companies_ktta_catalysts_20261116","title":"KTTA catalysts: Pasithea Therapeutics Corp. PDUFA dates and FDA events","publisher":"sec-api.dev","URL":"https://sec-api.dev/companies/ktta/catalysts","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
